Educating Infusion Nurses on Infection Risks of Anti-BCMA Bispecific Antibodies in MM Treatment

Video

Experts discuss how they educate infusion nurses and other colleagues treating patients with multiple myeloma on the infection risks of BCMA-targeting bispecific antibodies.

Recent Videos
4 experts in this video
4 experts in this video
4 experts in this video
4 experts in this video
Patients with high-risk markers may especially benefit from the addition of daratumumab to lenalidomide as maintenance therapy for NDMM.
Related Content